Cisatracurium Besylate Injection
Product Images NDC 0143-9160

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 0143-9160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisatracurium Besylate Structural Formula (Cisatracurium Besylate Injection Usp Pf 1)

Chemical structure diagram of Cisatracurium Besylate, showing the molecular components and arrangement including benzene rings and methoxy groups.*

FDA Label Image

Figure 1 (Cisatracurium Besylate Injection Usp Pf 2)

A scatter plot chart depicting data points related to heart rate (HR) and mean arterial pressure (MAP) changes, both ranging from -60% to +60%. The chart shows individual data points clustered near the origin, representing variations in HR and MAP percentages.*

FDA Label Image

Figure 2 (Cisatracurium Besylate Injection Usp Pf 3)

A scatter plot chart depicting data points in relation to heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis, both ranging from -60% to +60%. The chart shows the distribution of data points centered around the origin, illustrating variations in HR and MAP percentages.*

FDA Label Image

Cisatracurium 5 mL Label (Cisatracurium Besylate Injection Usp Pf 4)

Cisatracurium Besylate Injection, USP 2 mg/mL (10 mg per 5 mL) in a 5 mL single-dose vial. The label includes a warning about the drug being a paralyzing agent used for intravenous administration only. It is sterile, nonpyrogenic, preservative-free, and advises storage between 2°C to 8°C. Manufactured by HIKMA Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Cisatracurium 5ml Sdv Pf Carton (Cisatracurium Besylate Injection Usp Pf 5)

Box label for Cisatracurium Besylate Injection, USP 10 mg per 5 mL (2 mg/mL), an intravenous single-dose vial. Label indicates it is a paralyzing agent for intravenous use, manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. Storage instructions specify 2° to 8°C and protection from light.*

FDA Label Image

Representative Serialization Image (Cisatracurium Besylate Injection Usp Pf 6)

A product label for Cisatracurium Besylate injection by Hikma Pharmaceuticals USA Inc. The label displays a QR code alongside text fields for GTIN, serial number (SN), expiration date (EXP), and lot number (LOT), used for product identification and tracking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.